期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Homocysteine as a Biomarker for Predicting Disease-Free Survival in Breast Cancer
1
作者 Daniela Filippini Ierardi Luis Gustavo Raimundo +8 位作者 Gimena Aguiar Patrícia Bandeira Rueda Germano Luiz Henrique Gebrim Nelson Carvas Bruno Frederico Aguilar Calegare Vania D’Almeida Catarina Segreti Porto Miriam Galvonas Jasiulionis Mariangela Correa 《Advances in Breast Cancer Research》 2013年第2期24-31,共8页
Introduction: Breast cancer is the leading cause of cancer mortality among women. Some biomarkers and clinical features are used for the diagnosis and prognosis of this tumor, but no prognostic or predictive marker is... Introduction: Breast cancer is the leading cause of cancer mortality among women. Some biomarkers and clinical features are used for the diagnosis and prognosis of this tumor, but no prognostic or predictive marker is routinely available specifically for hormone receptor positive tumors. Homocysteine is well known as a risk factor in atherosclerotic vascular diseases, but its participation in cancer biology is still unclear. The aim of this study was to evaluate serum Homocysteine and Cysteine as biomarkers of disease progression in breast tumor. As a secondary objective, the effect of a short course (one month) of hormonal treatment on Homocysteine, Cysteine and DNA methylation levels was also evaluated. Methods: Blood samples, tumor samples and normal adjacent tissue were collected during the initial biopsy (pre-treatment) and after one month of hormonal therapy (post-treatment). Serum Homocysteine and Cysteine were analyzed by HPLC and tissue global DNA methylation was determined by the Methylation-Sensitive Restriction Enzyme (MSRE) technique. Results: Variations in Homocysteine levels were significantly correlated with Disease-Free Survival. Cox proportional risk model demonstrated that nodal status and Homocysteine levels were independent prognostic factors for disease-free survival (DFS). A significant difference was observed between pre-and post-treatment levels of Homocysteine and Cysteine in advanced tumors, suggesting a prognostic role in patients with poor clinical characteristics. Conclusion: Although more studies are needed to confirm these results, our research suggests that Hcy might be used as a prognostic biomarker for breast cancer. 展开更多
关键词 HOMOCYSTEINE CYSTEINE Breast Cancer ESTROGEN Receptor PROGNOSTIC and Predictive BIOMARKER TAMOXIFEN Anastrozol
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部